Related Experiment Videos

Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice

J R Gnarra1, J M Ward, F D Porter

  • 1Urologic Oncology Branch, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892, USA.

Insights

Von Hippel-Lindau (VHL) gene inactivation causes embryonic death due to placental failure. VHL gene expression is critical for placental vascular development and embryonic survival.

Area of Science:

  • Genetics
  • Developmental Biology
  • Oncology

Background:

  • Von Hippel-Lindau (VHL) disease is linked to VHL tumor suppressor gene inactivation.
  • VHL inactivation is an early event in sporadic renal cell carcinoma development.

Purpose of the Study:

  • To investigate the role of the VHL gene in embryonic development using a mouse model.
  • To determine the consequences of VHL gene inactivation on embryonic and placental development.

Main Methods:

  • Targeted homologous recombination was used to disrupt the VHL gene in murine embryonic stem cells.
  • A mouse line with an inactivated VHL allele was generated and analyzed for embryonic and placental phenotypes.

Main Results:

  • VHL -/- mice died in utero between embryonic days 10.5 and 12.5.
  • VHL -/- embryos exhibited placental dysgenesis, failed embryonic vasculogenesis, and hemorrhagic lesions.
  • These placental defects led to embryonic necrosis and death.

Conclusions:

  • VHL gene expression is essential for normal extraembryonic vascular development.
  • Placental failure due to VHL inactivation is the cause of embryonic lethality in VHL -/- mice.
  • This study highlights the critical role of VHL in placental development, impacting embryonic survival.

Related Concept Videos